Tags

Type your tag names separated by a space and hit enter

Update on menstrual migraine: from clinical aspects to therapeutical strategies.
Neurol Sci. 2004 Oct; 25 Suppl 3:S229-31.NS

Abstract

Migraine occurrence is strongly influenced by the hormonal fluctuations of the female reproductive cycle; at least 60% of women affected by migraine relate the periodicity of their attacks to the menstrual cycle. The so-called menstrual migraine, which occurs immediately before, during or at the end of the menstrual flow, has been a largely undefined condition, including some clinical subtypes which are not well defined. In the last edition of the International Classification of Headache Disorders (ICHD-II), menstrual migraine gained new attention in the Appendix, where three clinical patterns were pointed out: pure menstrual migraine without aura; menstrually related migraine without aura and non-menstrual migraine without aura. Menstrual migraine attacks show severe intensity, long duration (lasting even more than 72 h), marked unresponsiveness to pharmacological treatments, and present higher recurrence rate and work-related disability than non-menstrual attacks. The pharmacological treatment of menstrual migraine can require specific cyclic prophylactic approaches (non-steroidal anti-inflammatory drugs, coxibs, magnesium, long half-life triptans or oestrogen supplements in various formulations), but usually the low frequency of attacks suggests a first approach with specific symptomatic drugs. Preference should be given to triptans, due to their specificity in controlling migraine pain and its accompanying symptomatology; among them, in particular for sumatriptan, many specific studies proved a real effectiveness in the management of acute menstrual migraine attack.

Authors+Show Affiliations

Woman's Headache Center, Department of Gynecology and Obstetrics, University of Turin, Via Ventimiglia 3, I-10126 Turin, Italy. gb.allais@tiscali.itNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15549543

Citation

Allais, G, and C Benedetto. "Update On Menstrual Migraine: From Clinical Aspects to Therapeutical Strategies." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 25 Suppl 3, 2004, pp. S229-31.
Allais G, Benedetto C. Update on menstrual migraine: from clinical aspects to therapeutical strategies. Neurol Sci. 2004;25 Suppl 3:S229-31.
Allais, G., & Benedetto, C. (2004). Update on menstrual migraine: from clinical aspects to therapeutical strategies. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 25 Suppl 3, S229-31.
Allais G, Benedetto C. Update On Menstrual Migraine: From Clinical Aspects to Therapeutical Strategies. Neurol Sci. 2004;25 Suppl 3:S229-31. PubMed PMID: 15549543.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on menstrual migraine: from clinical aspects to therapeutical strategies. AU - Allais,G, AU - Benedetto,C, PY - 2004/11/19/pubmed PY - 2005/1/6/medline PY - 2004/11/19/entrez SP - S229 EP - 31 JF - Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology JO - Neurol Sci VL - 25 Suppl 3 N2 - Migraine occurrence is strongly influenced by the hormonal fluctuations of the female reproductive cycle; at least 60% of women affected by migraine relate the periodicity of their attacks to the menstrual cycle. The so-called menstrual migraine, which occurs immediately before, during or at the end of the menstrual flow, has been a largely undefined condition, including some clinical subtypes which are not well defined. In the last edition of the International Classification of Headache Disorders (ICHD-II), menstrual migraine gained new attention in the Appendix, where three clinical patterns were pointed out: pure menstrual migraine without aura; menstrually related migraine without aura and non-menstrual migraine without aura. Menstrual migraine attacks show severe intensity, long duration (lasting even more than 72 h), marked unresponsiveness to pharmacological treatments, and present higher recurrence rate and work-related disability than non-menstrual attacks. The pharmacological treatment of menstrual migraine can require specific cyclic prophylactic approaches (non-steroidal anti-inflammatory drugs, coxibs, magnesium, long half-life triptans or oestrogen supplements in various formulations), but usually the low frequency of attacks suggests a first approach with specific symptomatic drugs. Preference should be given to triptans, due to their specificity in controlling migraine pain and its accompanying symptomatology; among them, in particular for sumatriptan, many specific studies proved a real effectiveness in the management of acute menstrual migraine attack. SN - 1590-1874 UR - https://www.unboundmedicine.com/medline/citation/15549543/Update_on_menstrual_migraine:_from_clinical_aspects_to_therapeutical_strategies_ L2 - https://link.springer.com/10.1007/s10072-004-0292-6 DB - PRIME DP - Unbound Medicine ER -